DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Novel Drug Delivery Systems in the Spotlight-Drug Discovery Alert" report to their offering.
This edition of Drug Discovery Alert depicts life sciences trends across novel drug delivery systems (NDDS)
The Drug Discovery Alert reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.
The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Key Topics Covered:
1. Trend Overview
- Drug Delivery Systems
2. Technology Profiles
- Pioneering Digital Health and Smart Drug Delivery Systems
- Natural Monodisperse Phytoglycogen Nanomaterials for Advanced Drug DeliveryGlysantis, Inc.
- Facilitating the Transport of Drugs and Imaging Agents via Molecular Vectors
- Microneedle Pill with Hollow Needles
- New Liposomal Vesicles to Help Treat Coronary Artery Disease
- Biocompatible Targeted Cancer Therapy
- Nanoparticle-Based Technology to Improve Drug Bioavailability
3. Appendix
- Patents Related to Novel Drug Delivery Systems
- Industry Interactions
For more information about this report visit http://www.researchandmarkets.com/research/w692x3/novel_drug
